A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 47/26 (2006.01) A61P 19/02 (2006.01) A61P 37/06 (2006.01) C07K 14/705 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2634547
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous(SC) for treating immune system diseases and tolerance induction.
La présente invention concerne généralement des formulations stables comprenant des molécules de CTLA4Ig, comprenant des formulations lyophilisées et liquides pour administration par différentes voies comprenant, par exemple, des voies telles que les voies intraveineuse (IV) et sous-cutanée (SC) pour traiter des maladies du système immunitaire et l'induction de tolérance.
Borsadia Sunita
Dahlheim Charles E.
Dali Manisha M.
Gandhi Rajesh B.
Naringrekar Vijay H.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Stable protein formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable protein formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable protein formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1534149